Diane Brouilliard
Head of Talent & Networks @ Sante Ventures
Austin, United States
Diane Brouilliard is a Series B investor at Sante Ventures in Austin focused on Health Care and Biotechnology. Diane Brouilliard Head of Talent and Networks at Sante Ventures. Diane holds a bachelor of science degree in human organizational development at Vanderbilt University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Diane Brouilliard invests in
Stages Diane Brouilliard invests in
Countries Diane Brouilliard invests in
Investment Focus
Industry
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Medical Device 1 (50%)
- Health Diagnostics 1 (50%)
Stage
- Series B 1 (50%)
- Series C 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BioStable
|
BioStable is a cardiovascular device company that develops innovative new products for the treatment of cardiovascular diseases. The company is led by an experienced group of industry executives with expertise in rapid and effective medical device development. The organization incorporates core strengths in all areas of product developmentincluding quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. BioStable provides a competitive edge by minimizing time to market for cost-effective medical devices that deliver improved clinical outcomes. The company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease.BioStable was founded in | Series C / Feb 25, 2020 | |
|
BioStable
|
BioStable is a cardiovascular device company that develops innovative new products for the treatment of cardiovascular diseases. The company is led by an experienced group of industry executives with expertise in rapid and effective medical device development. The organization incorporates core strengths in all areas of product developmentincluding quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. BioStable provides a competitive edge by minimizing time to market for cost-effective medical devices that deliver improved clinical outcomes. The company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease.BioStable was founded in | $4.3M / Series B / Apr 29, 2015 |
Co-Investors
About Sante Ventures
Santé Ventures is a life sciences venture capital firm that invests exclusively in early-stage companies developing innovative new medical technologies or healthcare delivery models. The firm was founded in 2006 and has nearly $1 billion in capital under management.
Sante Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Casey Cunningham
Partner & Chief Scientific Officer
|
|||
David Kaufman
Chief Operating Officer
|
|||
Dennis McWilliams
Managing Director
|
|||
|
Diane Brouilliard
Head of Talent & Networks
|
|||
Douglas French
Co-Founder and Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Diane Brouilliard invest in?
Diane Brouilliard invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Diane Brouilliard last invest?
The most recent investment recorded for Diane Brouilliard closed in Feb 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
